6-[[3-[(二甲基氨基)羰基]苯基]磺酰]-4-[(3-甲氧基苯基)氨基]-8-甲基-3-喹啉甲酰胺
GSK256066;6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg 10 mg
Product Availability
3-5 days
Price
$48.00
Member price
Product Availability
3-5 days
Price
$106.00
Member price
Product Availability
3-5 days
Price
$166.00
Member price
Quantity
- +
Product Overview
Product Name GSK256066;6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide
CAS801312-28-7
FormulaC27H26N4O5S
MW518.58
MDLMFCD18206923
AppearanceLight yellow to yellow powder
Storage conditionStore short-term at 0-4°C or long-term at -20°C in a dry, dark place.
Security information
Product details

GSK256066 is a selective and high-affinity phosphodiesterase 4 (PDE4) inhibitor, with an IC50 value of 3.2 pM for inhibiting PDE4B. This compound has been developed for research into chronic obstructive pulmonary disease (COPD).

Related
Sorry, no related items
History
Fletikumab (Anti-IL-20)
Diquafosol
GSK256066;6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide
Glycerol (Synonyms: Trihydroxypropane)
Vonoprazan | TAK-438 free base
Lovastatin (Mevinolin)
2-[2-[2-(tetradecyloxy)ethoxy]ethoxy]ethyl palmitate
Sitaxsentan sodium | TBC11251 sodium salt | TBC11251
Vonoprazan Fumarate | TAK-438
Apatinib | Apatinib Free base | YN968D1| Rivoceranib